Cargando…
Reply: Procedural Characteristics and Medications to Prevent Sinus Node Artery Occlusion During Cardioneuroablation
Autores principales: | Rivarola, Esteban W., Scanavacca, Mauricio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803764/ https://www.ncbi.nlm.nih.gov/pubmed/36593765 http://dx.doi.org/10.1016/j.jaccas.2022.101720 |
Ejemplares similares
-
Procedural Characteristics and Medications to Prevent Sinus Node Artery Occlusion During Cardioneuroablation
por: Debruyne, Philippe
Publicado: (2022) -
Sinus Node Artery Occlusion During Cardiac Denervation Procedures
por: Scanavacca, Mauricio, et al.
Publicado: (2022) -
Author’s Reply—Atropine: Hero or villain in cardioneuroablation?
por: Thurber, Clinton J., et al.
Publicado: (2022) -
Reply to the Editor— The proper usage of electroanatomic mapping–guided cardioneuroablation
por: Antolic, Bor, et al.
Publicado: (2018) -
Selection of patients with symptomatic vagal-induced sinus node dysfunction: Who will be the best candidate for cardioneuroablation?
por: Cai, Simin, et al.
Publicado: (2023)